EMA Recommends Dropping Tecovirimat for Mpox

The decision was based on results of clinical trials suggesting its lack of effectiveness for mpox.
Medscape News Europe

Source link : https://www.medscape.com/viewarticle/ema-recommends-dropping-tecovirimat-mpox-2026a10009gq?src=rss

Author :

Publish date : 2026-03-27 14:08:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

EMA Recommends Dropping Tecovirimat for Mpox

Concerning COVID Variant Shows Up in 29 States

AI data centres can warm surrounding areas by up to 9.1°C

Related Posts

Brain Disease Decades Later? Study Links Childhood Surgery to Amyloid Build-Up

Lancet Retracts 1977 Commentary; Predicting Liver Cancer; Genetic Testing Fraud

He Suddenly Couldn’t Speak in Space. Astronaut Says Medical Scare Remains a Mystery.

Union Staff Strike at BMA Over Pay

ICI-Related Toxicity Diagnoses Differ for Dark vs Light Skin

What to Expect for Prior Authorization in 2026

Brain Disease Decades Later? Study Links Childhood Surgery to Amyloid Build-Up

Lancet Retracts 1977 Commentary; Predicting Liver Cancer; Genetic Testing Fraud

He Suddenly Couldn’t Speak in Space. Astronaut Says Medical Scare Remains a Mystery.

Union Staff Strike at BMA Over Pay

ICI-Related Toxicity Diagnoses Differ for Dark vs Light Skin

What to Expect for Prior Authorization in 2026

EMA Backs Orodispersible Furosemide for Edema in Children

FDA OKs Therapy for Deadly Pediatric Immune Disorder

Categories

Archives